Famotidine Tablet, Film Coated
FDA Label NDC 70771-1702

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Famotidine (NDC 70771-1702). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1702-3

Famotidine Tablets USP, 20 mg

30 Tablets

Rx only

20 mg Label (3e6a7405 B4c9 4034 8be6 41d8499ee9b2 01)

20 mg Label (3e6a7405 B4c9 4034 8be6 41d8499ee9b2 01)

NDC 70771-1703-3

Famotidine Tablets USP, 40 mg

30 Tablets

Rx only

40 mg Label (3e6a7405 B4c9 4034 8be6 41d8499ee9b2 02)

40 mg Label (3e6a7405 B4c9 4034 8be6 41d8499ee9b2 02)

* Please review the disclaimer below.